Dr. Mehta's research is focused on the molecular biology and the signaling pathways driving glioma biology.

Komal Singh's research interest focus is to improve cancer treatment-related outcomes by evaluating phenotypic and molecular risk factors for symptom occurrence and severity and determines underlying biological mechanisms.